title: Quinine-induced arrhythmia in a patient with severe malaria.
abstract: It was reported that there was a case of severe malaria patient with jaundice who presented with arrhythmia (premature ventricular contraction) while getting quinine infusion was reported. A man, 25 years old, was admitted to hospital with high fever, chill, vomiting, jaundice. The patient was fully conscious, blood pressure 120/80 mmHg, pulse rate 100 x/minute, regular. On admission, laboratory examination showed Plasmodium falciparum (++++), total bilirubin 8.25 mg/dL, conjugated bilirubin 4.36 mg/dL, unconjugated bilirubin 3.89 mg/dL, potassium 3.52 meq/L Patient was diagnosed as severe malaria with jaundice and got quinine infusion in dextrose 5% 500 mg/8 hour. On the second day the patient had vomitus, diarrhea, tinnitus, loss of hearing. After 30 hours of quinine infusion the patient felt palpitation and electrocardiography (ECG) recording showed premature ventricular contraction (PVC) > 5 x/minute, trigemini, constant type--sinoatrial block, positive U wave. He was treated with lidocaine 50 mg intravenously followed by infusion 1500 mg in dextrose 5%/24 hour and potassium aspartate tablet. Quinine infusion was discontinued and changed with sulfate quinine tablets. Three hours later the patient felt better, the frequency of PVC reduced to 4 - 5 x/minute and on the third day ECG was normal, potassium level was 3.34 meq/L. He was discharged on 7th day in good condition. Quinine, like quinidine, is a chincona alkaloid that has anti-arrhythmic property, although it also pro-arrhythmic that can cause various arrhythmias, including severe arrhythmia such as multiple PVC. Administration of parenteral quinine must be done carefully and with good observation because of its pro-arrhythmic effect, especially in older patients who have heart diseases or patients with electrolyte disorder (hypokalemia) which frequently occurs due to vomiting and or diarrhea in malaria cases.
authors.affiliation: Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine Mulawarman University/A. Wahab Sjahranie General Hospital, Samarinda.
authors.forename: Carta A
authors.initials: CA
authors.lastname: Gunawan
authors.forename: Paul N
authors.initials: PN
authors.lastname: Harijanto
authors.forename: Agung
authors.initials: A
authors.lastname: Nugroho
mesh_terms: D000328:Adult; D000962:Antimalarials / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008288:Malaria / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D011188:Potassium / Q000627:therapeutic use; D011803:Quinine / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D018434:Sickness Impact Profile; D012848:Sinoatrial Block / Q000139:chemically induced*; D018879:Ventricular Premature Complexes / Q000139:chemically induced*
chemical_list: D000962:Antimalarials; D008012:Lidocaine; D011803:Quinine; D011188:Potassium